What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Recognizing warning signs of a bad cryptocurrency investment can save you from significant losses. Stay alert and informed with our guide.
19,013 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A fresh study contrasts how traditional Medicare and Medicare Advantage manage stroke care, with potential implicatio...
For half a century, Warren Buffett has preached a steady approach to market downturns. This guide breaks down his les...
A fresh budget analysis casts doubt on solvency for Social Security and Medicare, even as Trump reiterates promises t...
The Department of Justice has waved through the Hart-Scott-Rodino review for the real brokerage remax merger, moving ...
MercadoLibre posted a solid Q4 revenue beat alongside an earnings miss, underscoring margin pressure from growth init...
Choosing between VEA and NZAC boils down to your priority: broad diversification in developed markets or a climate-al...
Bitcoin stirred market drama as it neared 69,000, triggering massive short liquidations. Across ethereum solana short...
Oracle shares slide as Larry Ellison funds a bid to steer a $110 billion media empire, triggering regulatory hurdles ...
Tech giants are forecast to spend a record $700 billion on AI data centers in 2026, signaling a durable AI buildout t...
Solana's SOL token flashed a buy signal, signaling a potential rally. Analysts see targets near $96 and $120 if momen...
One stock stands out as an underrated artificial intelligence (ai) play that Wall Street expects to power higher. Her...